Trial · NCT03457701
Results by group106
Each measurement the trial posted, group by group, in the words and numbers it posted.
61 to 80 of 106
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Periods 1 and 2: Change From Baseline in Hemoglobin Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 28 | -5.0 | Standard Deviation 5.87 | Grams per liter (g/L) |
| Periods 1 and 2: Change From Baseline in Hemoglobin Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 28 | 3.5 | Standard Deviation 3.39 | Grams per liter (g/L) |
| Periods 1 and 2: Change From Baseline in Hemoglobin Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 14 | -5.3 | Standard Deviation 4.80 | Grams per liter (g/L) |
| Periods 1 and 2: Change From Baseline in Hemoglobin Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 14 | 3.7 | Standard Deviation 3.01 | Grams per liter (g/L) |
| Periods 1 and 2: Change From Baseline in Hemoglobin Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 28 | -4.3 | Standard Deviation 10.19 | Grams per liter (g/L) |
| Periods 1 and 2: Change From Baseline in Hemoglobin Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 28 | 2.3 | Standard Deviation 2.94 | Grams per liter (g/L) |
| Periods 1 and 2: Change From Baseline in Hematocrit Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 14 | 0.002 | Standard Deviation 0.0086 | Proportion of red blood cells in blood |
| Periods 1 and 2: Change From Baseline in Hematocrit Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 14 | 0.011 | Standard Deviation 0.0144 | Proportion of red blood cells in blood |
| Periods 1 and 2: Change From Baseline in Hematocrit Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 28 | -0.017 | Standard Deviation 0.0183 | Proportion of red blood cells in blood |
| Periods 1 and 2: Change From Baseline in Hematocrit Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 28 | 0.009 | Standard Deviation 0.0139 | Proportion of red blood cells in blood |
| Periods 1 and 2: Change From Baseline in Hematocrit Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 14 | -0.006 | Standard Deviation 0.0205 | Proportion of red blood cells in blood |
| Periods 1 and 2: Change From Baseline in Hematocrit Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 14 | 0.009 | Standard Deviation 0.0105 | Proportion of red blood cells in blood |
| Periods 1 and 2: Change From Baseline in Hematocrit Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 28 | -0.010 | Standard Deviation 0.0343 | Proportion of red blood cells in blood |
| Periods 1 and 2: Change From Baseline in Hematocrit Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 28 | 0.002 | Standard Deviation 0.0114 | Proportion of red blood cells in blood |
| Periods 1 and 2: Change From Baseline in Erythrocytes Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 14 | 0.05 | Standard Deviation 0.138 | 10^12 cells/liter |
| Periods 1 and 2: Change From Baseline in Erythrocytes Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 14 | 0.13 | Standard Deviation 0.137 | 10^12 cells/liter |
| Periods 1 and 2: Change From Baseline in Erythrocytes Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 1, DAY 28 | -0.13 | Standard Deviation 0.163 | 10^12 cells/liter |
| Periods 1 and 2: Change From Baseline in Erythrocytes Following Treatment With Daprodustat and rhEPO | rhEPO | Period 1, DAY 28 | 0.13 | Standard Deviation 0.082 | 10^12 cells/liter |
| Periods 1 and 2: Change From Baseline in Erythrocytes Following Treatment With Daprodustat and rhEPO | Daprodustat | Period 2, DAY 14 | -0.17 | Standard Deviation 0.225 | 10^12 cells/liter |
| Periods 1 and 2: Change From Baseline in Erythrocytes Following Treatment With Daprodustat and rhEPO | rhEPO | Period 2, DAY 14 | 0.13 | Standard Deviation 0.121 | 10^12 cells/liter |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03457701/results?page=4